Current Biology 27, R825-R832, September 11, 2017 R827 of human uniqueness. Predictably, he follows the received wisdom that the nascent cognitive capacities in a number of species, consistent of course with the undoubted evolutionary continuity between humans and other species, provide a bridge that is reinforced by the archaeological record. But just how secure is this bridge? What Thomas Suddendorf has labelled as 'The Gap' may yet open some unexpected doors, not least in terms of language, mathematics and music.
These questions, of course, go far beyond what Losos has set out to do, but we should all appreciate the irony that only one species knows that it has evolved, and at least some of its representatives fi nd this fascinating. So too, only we would wish to know if animal vocalizations are a sort of proto-language (seemingly not), that mathematics emerged from numerosity (most unlikely) or that a direct line of continuity runs between whale song and the closing section of Götterdämmerung (if you believe that you'll believe anything).
The acid test to all these points, and indeed the entire thesis presented in Losos' challenging book, will be the documentation of extraterrestrial biospheres. Losos presents us with an intriguing list of some of the alternative possibilities. When, however, I recall that a dog and a cockroach walk in very much the same way, that leaky membranes will generate warmth, plants will evolve seeds and reptiles a placenta, then I am moderately confi dent that, however bizarre in appearance these organisms might be, on closer inspection, our extraterrestrial counterparts will be remote only in terms of the parsecs that currently separate us.
So, after this robust defence of convergence, surely I will continue to man the barricades, dodging the bullets and smiling sweetly at the swirling crowds? Hardly necessary. In Current Biology alone since the beginning of this year I count at least six mainstream papers on convergence. Quite frankly, the whole business is becoming far too popular. Time to move on. What turned you on to biology in the fi rst place? I was one of those 'nerds' who collected anything that moved -always taking stuff apart and not always putting it all back together again. As I grew older, I planned to study medicine, but always kept a keen eye on biology. However, reality has the habit of rearranging our plans in unexpected ways, which happened to my family when in 1973 Allende's government was overthrown by the Pinochet military coup. Although we stayed in Chile for more than a year afterwards, we eventually left in December of 1974 and settled in Sussex, UK, where my father was invited to be a professor of economics at the University of Sussex. Coincidentally, biology was becoming very strong at Sussex at this time as well.
What drew you to your specifi c fi eld of research? Once we left Chile, I applied to UK universities and found that, after all, I did not have to do medicine to study life sciences. I realized I could actually study biology, which is what I really wanted, especially after the last two years at school when I had great teachers in biology and physics. The University of Sussex was a relatively new university at the time, but had already made a really solid name in the biological sciences, so it was an obvious choice. In my initial studies there, my classes were small and there was great emphasis on research.
Who were your key early infl uences? Robert Whittle, developmental biologist and geneticist, who was responsible for teaching classical and developmental genetics, was a great mentor. It all started during a practical class in which we were doing a gene-mapping experiment, using one of the greatest model organismsthe fruit fl y Drosophila. I noticed a fl y that had its wings spread out like an airplane. It could not fl y, but walked with its wings spread out like a child playing. Robert then asked me whether I would be interested in mapping the mutation. Friday afternoons and sometimes weekends became regular days at the lab, where I became fascinated with biology. From then on, I never stopped going the extra mile.
I also worked with Chris Ford trying to isolate a DNA replication inhibitor from Xenopus oocytes, and with Brian Goodwin on a modeling project to create a gene network with stable oscillatory behavior. I spent endless lunchtimes in the animal house studying the pairing behavior of fi nches -yes, Darwin's fi nches. There were great scientists at Sussex working on developmental biology (e.g., Peter Bryant), cell cycle (e.g., Paul Nurse) and population genetics (e.g., Brian and Deborah Charlesworth, as well as John Maynard Smith). It was all very exciting! Which key developments in biology marked your path? There was a lot of science fl oating about in many different forms. I completed my PhD, at Sussex, in 1983 working on a gene that we called Brista and was later renamed, much to Michael Asburner's dislike, Distaless. Dll is a homeodomain transcription factor involved in the determination of distal structures of appendages throughout metazoans. Although genetics and development were the 'hot topics' of the time, I felt the need to move topics R828 Current Biology 27, R825-R832, September 11, 2017 after my PhD, and knew that the future of biology would require molecular studies. We needed to know the genes involved, their regulation, the proteins encoded, and how they interacted in networks of events that lead to the formation of an organism. So, while looking for a postdoc, I came across David Glover, who had returned from USA after working with Hogness on rDNA. Although I must confess that rDNA did not make me lose any sleep, the project he wanted to develop at Imperial College sounded exactly what I wanted to do. So, after living in 'utter luxury' in Brighton, I headed up to the big city where I ended up renting a tiny studio fl at, somewhere near Tooting Bec Station, long before there was anything fancy or trendy about South London.
What was best about being at Imperial College? Biochemistry at Imperial was amazing. Peter Rigby down the corridor editing for Cell; David Lane playing with p53; Cori Gorman with her CAT assays; and David Glover putting together an exciting new research program. Glover wanted to combine molecular biology and genetics to hunt for key cell-cycle regulatory genes. He had become aware of the potential of early Drosophila embryogenesis where, using antibodies, we could see subcellular structures such as centrosomes and the mitotic spindle. Using Christiane Nüsslein-Volhard's library of mutations that resulted in early embryo lethality, there was the opportunity to identify mutations that affected the normal course of cell divisions, which we could map and eventually clone.
The second component of this research program came with the arrival of Roger Karess, who had worked with Gerry Rubin on the P-element used for the fi rst Drosophila transformation experiments. He created a library of P-element-induced mutations that caused fl ies to die late in their third instar larval stage when diploid cell division was essential. Pedro Ripoll (in Madrid) and Maurizzio Gatti (in Rome) had shown that many mutations affecting late larval development were characterized by alterations in cell division and chromosome segregation.
How did you benefi t from all this?
When I arrived at Imperial, I took advantage of all the opportunities. I identifi ed from the female-sterile collection a mutant whose nuclei were capable of replicating their DNA but could not segregate it. There were abnormal spindles with no centrosomes. Bingo!!! The gene was required for chromosome segregation in all cells, including during meiosis. I called it Polo, for 'pole' in Spanish, since I thought its normal function was required to build the centrosomes responsible for the organization of the mitotic spindle in animal cells (and I was not wrong) . Surprisingly, in the absence of centrosomes, DNA replication and chromosome segregation could be uncoupled, suggesting that there might be two separate components to cell division -the nuclear cycle and the cytoplasmic cycle, coordinated by the centrosome. On the fi rst run of complementation tests, I got two clear hits with Roger's P-element mutant collection. One turned out to be Polo, which with the invaluable help of Salud Llamazares and Cayetano Gonzalez, we cloned and published in 1991. I had done the full cycle and ended up cloning a kinase that turned out to be a key player in the orchestration of cell division, which, together with Aurora B and Cdk1, executes the cell cycle.
If you had to choose a different fi eld of biology, what would it be?
Many times I have thought about this, and there is one area of biology that I fi nd fascinating and that I could have done with enormous pleasure -in vitro fertilization. I have always been fascinated by early embryo development, which bridges together the life and the health sciences. If you ever had the chance to see a two-cell stage human embryo in progress, you would never forget it. It is a truly amazing sight.
Why did you move to Portugal? As I mentioned before, reality has the habit of changing our plans. While I was enjoying my postdoc, Gabriela, my wife, had to go back to Portugal to fulfi l her contract with her home university after her PhD at Sussex. We commuted between Porto and London, and even though science in Portugal was not well developed, I started to explore opportunities there. Portugal had just entered the EU, our son was due to be born, and I eventually moved to Portugal in July of 1987, with the promise of a contract in the Oncology Hospital in Porto. I ended up at the Center for Experimental Cytology at the University of Porto, where I started my own lab. From making the fl y food at home to doing live imaging or superresolution microscopy at our current institute, 30 fantastic years have passed.
What do you think your contribution has been in that country? We both gave each other a lot. The country gave me a second home, and above all else gave me a sense of world history. During these 30 years, I worked hard, not only in my lab and teaching duties, but also in the development of a successful system of science and technology. In 1997, we created the IBMC (Institute for Cell and Molecular Biology), and afterwards in 2015, the Institute for Research and Innovation in Health (i3S), both at the University of Porto. It has been an incredible journey, not only of scientifi c discovery, but also of development of the life sciences in Portugal. I've also been active in the development of science in Europe, through my commitment to EMBL, where I was chair of the council, and also with EMBO, where I collaborated in many initiatives and to whose council I was recently elected. However, what I think gives me the most pleasure is to see our vibrant community of young Portuguese biologists, most of whom I knew as a teacher, mentor or advisor, and many of whom are now leaders in their fi elds and have taken cell and molecular biology to new heights.
What is the best advice you've been given? I think the best advice I was ever given was by Robert Whittle, who once told me that the only stupid question is that which you failed to ask because you were afraid or ashamed of showing your ignorance.
Any person in particular that marked your past? I have met many great people in my career that, in one way or another, have given me a lot. Robert, who suddenly passed away a few years ago, showed me his passion for science and taught me how to ask questions. David Glover is a great molecular biologist and friend. I have learned a lot from Cayetano Gonzalez, for his incredible attention to detail -because as they say, the devil is in the detail. In Portugal, Mariano Gago, minister of Science in Portugal, taught me that we always have to be true to what we believe. Also, Manuel Teixeira da Current Biology 27, R825-R832, September 11, 2017 © 2017 Elsevier Ltd. R829 Silva, a microbiologist, received me in his lab and gave me all the encouragement to succeed. However, my gratitude goes to all my technicians, students and postdocs who really made the lab a wonderful place.
What do you think are the big questions to be answered next in your fi eld? Big data analysis and high-throughput techniques are for the fi rst time giving us a picture of biological organization that could reveal the mechanisms by which the emerging properties of living systems are governed. However, at present, we are just ploughing through biological complexity, and it looks like we are moving very slowly. So, one of the biggest challenges at present is to correctly place the different levels of genetic information -from transcription, to the epigenetic code, into the language of microRNAs and to the mechanisms of non-coding RNA and the role of targeting proteins to specifi c sites in the genome. My humble guess is that, while probably most of the pieces are known, we are left with a puzzle for which we have no blueprint, and that we know little about the rules that govern how the different levels of information interact in time and space.
What is the project that really moves you at present? I basically have three projects currently. Firstly, I still spend a signifi cant part of my time thinking, talking and mentoring the people in my lab, where we study the mechanisms that govern chromosome segregation and genomic stability, and how this relates to tumorigenesis. Secondly, I am engaged in a project that started some 10 years ago, which has merged three institutes of the University of Porto into a large interdisciplinary research centre. The Institute for Research and Innovation in Health is now a reality that aims to contribute to solving some major health issues, like neurodegenerative diseases, host-pathogen interaction, and cancer. Finally, since I have always enjoyed immensely my teaching, and I would like to transform my lecture series into a text book because there is always so much more to learn. (Figure 1 ). Based on this close evolutionary relationship, Capsaspora is becoming pivotal to understanding the origins of animal multicellularity.
Why is this tiny amoeba so special?
Besides its phylogenetic position, it has recently been shown that Capsaspora has an aggregative multicellular stage, something that had not previously been seen among unicellular relatives of animals.
Quick guide
Aggregative multicellularity, where it occurs, is usually a temporally defi ned, transient stage of the life cycle of a unicellular organism. It has been reported in only a few eukaryotic taxa, such as Dictyostelium and other amoeboid organisms. This behaviour is also found in some animal cells, such as mesenchymal and germ-cell lines, during development.
In the case of Capsaspora, aggregative behaviour represents one of the three stages of its life cycle. Capsaspora's growth stage begins with individual amoebas that produce fi lopodia. The growth stage can be followed by either a cystic stage without cell protrusions, or by an aggregative stage, in which amoebas gather together and form a multicellular structure embedded within an extracellular matrix that holds them together.
Can Capsaspora help elucidate the origins of animal multicellularity? Yes. Given that Capsaspora is a close unicellular relative of animals, comparisons of its morphological and genomic features with those of animals can provide insights into their shared common ancestor. This is why researchers have sequenced the full nuclear and mitochondrial genomes, as well as obtained the transcriptome, proteome, phosphoproteome and histone post-transcriptional modifi cations from its three life stages.
Additionally, Capsaspora has a rare and much sought-after characteristic 
